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Abstract
Background: The vascular endothelium plays a critical role in the control of blood flow. Altered endothelium-mediated
vasodilator and vasoconstrictor mechanisms underlie key aspects of cardiovascular disease, including those in obesity.
Whilst the mechanism of nitric oxide (NO)-mediated vasodilation has been extensively studied in obesity, little is known
about the impact of obesity on vasodilation to the endothelium-derived hyperpolarization (EDH) mechanism; which
predominates in smaller resistance vessels and is characterized in this study.
Methodology/Principal Findings: Membrane potential, vessel diameter and luminal pressure were recorded in 4
th order
mesenteric arteries with pressure-induced myogenic tone, in control and diet-induced obese rats. Obesity, reflecting that of
human dietary etiology, was induced with a cafeteria-style diet (,30 kJ, fat) over 16–20 weeks. Age and sexed matched
controls received standard chow (,12 kJ, fat). Channel protein distribution, expression and vessel morphology were
determined using immunohistochemistry, Western blotting and ultrastructural techniques. In control and obese rat vessels,
acetylcholine-mediated EDH was abolished by small and intermediate conductance calcium-activated potassium channel
(SKCa/IKCa) inhibition; with such activity being impaired in obesity. SKCa-IKCa activation with cyclohexyl-[2-(3,5-dimethyl-
pyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine (CyPPA) and 1-ethyl-2-benzimidazolinone (1-EBIO), respectively, hyperpolarized
and relaxed vessels from control and obese rats. IKCa-mediated EDH contribution was increased in obesity, and associated
with altered IKCa distribution and elevated expression. In contrast, the SKCa-dependent-EDH component was reduced in
obesity. Inward-rectifying potassium channel (Kir) and Na
+/K
+-ATPase inhibition by barium/ouabain, respectively, attenuated
and abolished EDH in arteries from control and obese rats, respectively; reflecting differential Kir expression and distribution.
Although changes in medial properties occurred, obesity had no effect on myoendothelial gap junction density.
Conclusion/Significance: In obese rats, vasodilation to EDH is impaired due to changes in the underlying potassium
channel signaling mechanisms. Whilst myoendothelial gap junction density is unchanged in arteries of obese compared to
control, increased IKCa and Na
+/K
+-ATPase, and decreased Kir underlie changes in the EDH mechanism.
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Introduction
Obesity is at epidemic levels, with cardiovascular dysfunction being
a common outcome [1]. Obesity is associated with an increased
incidence of type-2diabetes, hypertension,stroke,metabolic syndrome,
peripheral arterial disease and myocardial infarction, and thus makes a
significant contribution to premature death [1]. However, the
mechanisms of vascular dysfunction in obesity are poorly understood.
Vascular tone refers to the balance between constrictor and dilator
influences and is critical for the control of blood flow and pressure,
and thus for normal cardiovascular function. The endothelium is a
major regulator of vascular tone, producing vasoconstrictor agents
such as metabolites of arachidonic acid, superoxide anions,
angiotensin II and endothelin-1 [2], and vasodilator action due to
nitric oxide (NO), cyclooxygenase and a NO/cyclooxygenase-
independent endothelium-derived hyperpolarization (EDH) mecha-
nism [3,4,5]. Characterization of the EDH response in health and
disease is critical, as such activity generally underlies the primary
vasodilator mechanism in the smaller resistance vessels that are
integral for control of vascular tone and blood flow [4,6,7].
The EDH response is well characterized in rat mesenteric
artery. In this vessel, agonist-induced EDH is dependent on
inositol 1,4,5-trisphosphate (IP3)-mediated release of intracellular
calcium [5,8,9] and subsequent endothelial small (S) and
intermediate (I) conductance calcium-activated potassium channel
(KCa) activation [3,5]. In turn, these channels release K
+ into the
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hyperpolarizing current which is transferred to smooth muscle via
myoendothelial gap junction connexins (Cxs [10,11,12]). Hyper-
polarization is also initiated via K
+ in the localized myoendothelial
space activating smooth muscle Na
+/K
+ATPase, whilst endothe-
lial cell inward rectifying potassium channels (Kir) may be involved
in amplifying the response [13]. The net smooth muscle
hyperpolarization facilitates closure of voltage-dependent calcium
channels to initiate vessel relaxation [3,5]. In healthy normal adult
rat mesenteric artery, a significant proportion of potassium and
Cx-mediated signaling, which are essential for EDH, occurs at
localized myoendothelial microdomain sites [5,10,11,12,13].
Vascular disease associated with endothelial dysfunction
includes type-2 diabetes and hypertension (for review [6]) linked
to obesity. Indeed, EDH is impaired in mesenteric artery of
insulin-resistant type-2 diabetic obese Zucker rats, via altered KCa
[14] and gap junction Cx-dependent [15] EDH mechanisms.
Further, in skeletal muscle saphenous artery branches of the diet-
induced obese rat, myoendothelial microdomain gap junctions
and IKCa are upregulated and account for EDH activity [16].
In the present study, the ability of 4
th order mesenteric arteries
to develop myogenic tone provides a physiologically relevant
framework from which to examine vasodilation. Indeed, mesen-
teric arteries from control and diet-induced obese rats develop
myogenic tone at physiologically relevant pressure (80 mmHg;
[17]). This is in contrast to altered myogenic tone in skeletal and
renal arterioles of the Zucker rat [18,19], but similar to
observations in diet-induced obese rat gracilis muscle and
coronary arterioles [20,21], as well as human forearm vessels
from obese individuals [22]; suggesting that the genetic Zucker
obesity model does not generally reflect the diet-induced obese
state in humans. Further, in contrast to the leptin receptor-
deficient Zucker rat, where obesity develops independently of
circulating leptin [23], the diet-induced obese rat directly reflects
common forms of human obesity, where leptin, insulin, glucose,
triglycerides and blood pressure are elevated [1,23,24,25,26].
The present study aimed to examine the effect of diet-induced
obesity on EDH-mediated function and the underlying mecha-
nisms in rat mesenteric artery with myogenic tone.
Results
General features of diet-induced obese rats
The effect of dietary intervention on biochemical and metabolic
parameters was characterized in control and obese rats. Following
the 16–20 week diet intervention, animals on the obese diet were
,37% heavier than age-matched controls (P,0.05; Table 1).
Body length, kidney and liver weight, retroperitoneal and gonadal
fat mass, blood glucose, insulin and leptin levels of obese animals
were significantly elevated (P,0.05) compared to controls
(Table 1).
Effect of obesity on general anatomical vessel
characteristics
The effect of dietary intervention on mesenteric artery
morphology was characterized in control and obese rats.
Mesenteric arteries from obese rats had a significant increase in
medial smooth muscle cell layers, medial thickness and media to
lumen ratio compared to control (P,0.05; Table 2, Figs. 1, S1).
No differences were observed in vessel diameter or medial cross
sectional area (Table 2). Myoendothelial gap junctions were
identified in both control and obese arteries and were present at
the same density and proportion of IEL holes in arteries of control
and obese rats (Table S1, Fig. 1).
Effect of obesity on the myogenic response
The effect of dietary intervention on the myogenic response was
characterized in mesenteric artery of control and obese rats.
Arteries from both control and obese rats routinely developed
myogenic tone (Fig. 2A, B), although there was no difference in the
degree of constriction at 80 mmHg between diet groups (Table
S2). The Dmax in 0 mM Ca
2+ physiological salt solution was not
significantly different in arteries from control and obese rats (Table
S2). Intracellular recordings from smooth muscle cells showed that
resting membrane potential at 80 mmHg was also not significantly
different between the two groups (Fig. 3A; Table S3).
Mesenteric artery EDH
5w?>The effect of dietary intervention on the characteristics of
EDH was characterized in mesenteric artery of control and obese
rats. In the presence of Nv-Nitro-L-arginine methyl ester hydrochlo-
ride (L-NAME; 1 mM), 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-
one (ODQ; 100 mM) and indomethacin (10 mM), acetylcholine
(ACh; 1 mM) produced a hyperpolarization and relaxation, which
was impaired in arteries from obese animals (P,0.05, Fig. 3A, B). In
arteries from both diet groups, combined apamin (50 nM) and 1-[(2-
chlorophenyl)diphenyl-methyl]-1H pyrazole (TRAM-34; 1 mM),
blockers of SKCa and IKCa respectively, abolished ACh-induced
hyperpolarization and relaxation (P,0.05, Fig. 3B), while apamin
and TRAM-34, in the absence of ACh, had no significant effects on
vessel diameter (Table S2). Of note, in 4
th order mesenteric arteries,
the ACh response in the presence of L-NAME, ODQ and
indomethacin was not different compared with EDH associated
relaxation evoked byACh in the absence oftheseblockers(TableS2),
consistent with the primary contribution of EDH to endothelium-
dependent relaxation in such small distal mesenteric vessels [27].
Hyperpolarization and relaxation of mesenteric artery smooth
muscle could also be evoked by a combination of the concentration
selective SKCa and IKCa agonists cyclohexyl-[2-(3,5-dimethyl-pyrazol-
1-yl)-6-methyl-pyrimidin-4-yl]-amine (CyPPA; 30 mM [16,28,29]) and
1-ethyl-2-benzimidazolinone (1-EBIO; 300 mM [16,30]) in arteries
from control and obese rats (P,0 . 0 5 ,F i g .3 C ) .T h em a g n i t u d eo ft h i s
response was similar to that recorded in the presence of ACh (Fig. 3B).
Likewise, apamin and TRAM-34 in combination, blocked the CyPPA/
1-EBIO evoked hyperpolarization and relaxation (P,0.05, Fig. 3C).
IKCa-dependent EDH is upregulated in obese rat
mesenteric artery
The effect of dietary intervention on the selective characteristics
of SKCa and IKCa-dependent EDH was characterized in
Table 1. Control and diet-induced obese rat characteristics.
Control (n=65) Obese (n=45)
Body weight (g) 53066 723615*
Body length (cm) 25.560.1 26.760.1*
Blood glucose (mM) 8.160.1 9.760.3*
Insulin (ng/ml) 4.560.5 12.660.5*
Leptin (ng/ml) 5.360.2 9.160.2*
Kidney (g) 1.560.1 1.860.1*
Liver (g) 17.760.3 24.560.8*
Retroperitoneal fat (g) 6.260.2 21.861.1*
Gonadal fat (g) 8.860.3 24.761.0*
*, P,0.05, compared to control.
doi:10.1371/journal.pone.0016423.t001
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the mesenteric artery EDH response was investigated using
apamin and CyPPA (Fig. 4A, B). Inhibition of SKCa with apamin
reduced ACh-induced EDH in arteries from both control and
obese rats (P,0.05; Fig. 4A), although SKCa contribution to EDH
was greater in arteries from control (P,0.05; Table S3). Further,
direct activation of SKCa by CyPPA evoked hyperpolarization and
relaxation which was not different between arteries from control
and obese rats (P.0.05; Fig. 4B); this response being blocked by
apamin (P,0.05), and returning to normal resting conditions in
arteries from control and obese animals.
In arteries from control animals, IKCa inhibition with TRAM-
34 reduced ACh-mediated hyperpolarization and the associated
relaxation (P,0.05; Fig. 4C). However, hyperpolarization and
relaxation were abolished by TRAM-34 in mesenteric arteries
from obese rats (Fig. 4C). IKCa activation by 1-EBIO caused a
smooth muscle hyperpolarization that was larger in arteries from
obese compared to control animals (P,0.05; Fig. 4D). In this
series of experiments, the larger hyperpolarization evoked by 1-
EBIO in arteries from obese animals was associated with increased
relaxation (P,0.05; Fig. 5D). TRAM-34 abolished the 1-EBIO
induced hyperpolarization and relaxation (n=4, P,0.05, Fig. 4D).
SKCa and IKCa protein in obesity
In order to determine whether the changes in SKCa and IKCa
activity in diet-induced obese rat mesenteric artery reflect altered
IKCa protein distribution, characterized antibodies were used with
confocal immunohistochemistry and, for IKCa only, Western
blotting, on whole arteries.
SK3 (SKCa) and IK1 (IKCa) distribution was determined using
confocal immunohistochemistry (Fig. 5). When series of images
were taken across the full depth of the vessel wall, reconstruction
revealed the presence of SK3 labelling in both control and obese
rat arteries as diffuse localization across the cell surface and the
cytoplasm of endothelial, but not smooth muscle cells, with such
labeling not being associated with IEL hole sites (Fig. 5iv, viii). In
Figure 1. Morphology of control and obese rat mesenteric artery. The media of obese rat mesenteric arteries contain more smooth muscle
cell (SMC) layers than control (A, B; Table 2). Myoendothelial gap junctions were present on endothelial cell (EC) projections in both control and
obese arteries (C, D and insets). Such sites have characteristic pentalaminar gap junction morphology (inset, between arrows). adv, adventitia; IEL,
internal elastic lamina; nb, nerve bundle. Bars; A, B,1 0mm; C, D,1mm; inset, 100 nm.
doi:10.1371/journal.pone.0016423.g001
Table 2. Control and diet-induced obese rat mesenteric artery characteristics.
Diameter
(mm) # SMC layers Medial thickness (mm)
Medial CSA
(mm
2) Media to lumen ratio (610
22)
Control 199621 2.960.2 10.460.4 33036323 4.9060.27
Obese 221612 3.960.3* 12.960.6* 38776238 6.1860.26*
n=8, each from a different rat.
*, P,0.05, compared to control. CSA, cross-sectional area; SMC, smooth muscle cell.
doi:10.1371/journal.pone.0016423.t002
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localization and discrete, punctate densities, which correspond to
,77 and ,23% of IEL holes in arteries from control and obese
rats, respectively (Fig. 5i–iii and 5v–vii, respectively; Table S1).
In addition, IK1 (IKCa) expression was determined using
Western blotting (Fig. 6). Western blotting of IKCa using optimal
selective antibodies (Tables S4 compared to S5) in the vasodilator
field has the common problem that in general it is assumed that
the molecular weight of the native single channels (,48 kDa),
reflects that of the functional channel (for example [14,31,32]).
However, this is not the case, as high molecular weight complexes
of these channels constitute the functional channel in both isolated
cells and intact tissue [33,34,35], and thus, the expression of such
complexes (and not the monomers) is of primary relevance for
studies of functional KCa expression; and hence the reason for the
focus on such complexes in the Western blotting of the present
study. Further details of specific aspects of the IKCa quantification
are included in Results S1.
Data show that IKCa were expressed in mesenteric arteries from
control and obese animals (Fig. 6). IK1 appeared as a smeared
band, characteristic of glycosylated and/or hydrophobic mem-
brane proteins possessing multiple phosphorylation sites [36,37].
Expression of the monomeric form of IK1 (,48 kDa) did not
differ between arteries of control and obese animals in either the
soluble or membrane extracts (Fig. 6A). However, a high
molecular weight IK1 complex that migrated at .220 kDa was
present (Fig. 6A). This complex was more highly expressed in the
membranes extracted from mesenteric arteries of obese animals
(,5.4-fold; P,0.05; Fig. 6A, D) and was absent from soluble
extracts (data not shown).
The antibodies used in this study have been previously
characterized using transfected cells and positive and negative
controls, and shown to be fully selective [33,34,35], with peptide
block of the primary antibodies abolishing staining of the bands
corresponding to the IK1 proteins (Fig. 6C).
Gap junction/connexin involvement in EDH
To clarify the potential functional role of heterocellular coupling
in EDH activity in control and obese rat mesenteric arteries,
membrane potential and vessel diameter were recorded in the
presence of the putative gap junction uncoupler carbenoxelone
(100 mM). In the presence of L-NAME (1 mM), ODQ (100 mM)
and indomethacin (10 mM), carbenoxelone significantly reduced
the ACh-mediated hyperpolarization in arteries from control and
obese animals (P,0.05; Table S3). Carbenoxelone however, had
no apparent effect on ACh-evoked relaxation in mesenteric
arteries from control or obese animals (Table S2).
K
+ mediates EDH via decreased Kir and increased
Na
+/K
+-ATPase activation in obesity
The effect of dietary intervention on the selective characteristics
of Kir- and Na
+/K
+-ATPase-dependent EDH was characterized
in mesenteric artery of control and obese rats. Inhibition of Kir
and Na
+/K
+-ATPase by combined barium (30 mM) and ouabain
(100 mM), respectively, reduced ACh-evoked EDH in arteries
from control rats (P,0.05; Fig. 7A; Tables S2,S3), with barium
alone causing a similar reduction in the magnitude of hyperpo-
larization and relaxation as combined Kir and Na
+/K
+-ATPase
block (P,0.05; Fig. 7B). In contrast, exposure to barium and
ouabain in arteries from obese animals abolished ACh-evoked
EDH (P,0.05), whilst barium alone caused a small, but significant
reduction in ACh-induced EDH (n=4; P,0.05), with no
significant effect on EDH-mediated relaxation (n=4; Fig. 7B;
Tables S2,S3).
Confocal immunohistochemistry using characterized antibodies
to examine the distribution of Kir in arteries from control and
obese rats revealed distinct punctate staining across the endothelial
cell surface in arteries from control rats, with a low level of cell
membrane/cytoplasmic Kir labeling; both of which could not be
detected in the endothelium of obese rat arteries (Fig. 7C). Kir
labeling was absent in the smooth muscle (Fig. 7Ciii, vi, insets).
Like IKCa, in control arteries, a proportion of localized Kir
densities corresponded with IEL holes, as potential myoendothelial
microdomain/gap junction sites (Figs. 7Ci–iii, 8).
Use of Na
+K
+-ATPase a1 and a2 subunit-directed antibodies
(Santa Cruz; sc-16043 and 31391, respectively) at serial dilutions
of 1:100–800 with confocal immunohistochemistry (in control
artery only; n=3) produced inconclusive results. Antibody
preincubation in a 10-fold excess of peptide corresponding to
the sequences of these a1 and a2 antibodies only partially blocked
apparent staining, and labeling was also present in endothelial cells
with a similar intensity to that in the adjacent smooth muscle
(suggesting non-specificity). Thus, further determination of
Na
+K
+-ATPase distribution was not conducted. No difference in
immunohistochemical antigen distribution was present with
aldehyde compared to solvent fixation.
Discussion
In the rat mesenteric artery, as a model bed for resistance vessel
studies, impaired EDH activity underlies endothelial dysfunction
associated with diet-induced obesity. In obese rat mesenteric
artery, altered EDH is due to K
+ release via upregulated
endothelial IKCa and subsequent activation of smooth muscle
Na
+/K
+-ATPase, whilst endothelial Kir expression is reduced and
myoendothelial gap junction density is unchanged compared to
control. Increased IKCa expression and redistribution, and
reduced SKCa and Kir function, and altered distribution in
arteries from obese rats, support the presence of plasticity in the
potassium channel signaling mechanisms that underlie EDH in the
mesenteric artery of obesity-related disease. Functional IKCa
upregulation has been previously reported in mesenteric artery of
stroke-prone spontaneously hypertensive rats, where EDH is
impaired [38]. Indeed, alterations in both the functional
Figure 2. Myogenic response. Representative traces of myogenic
tone development in arteries from control (A) and obese (B) animals
with stepped pressure increases. At 80 mmHg, no difference was
observed in the degree of constriction in control compared to obese
arteries, with ACh (1 mM) relaxing arteries from control and obese rats.
doi:10.1371/journal.pone.0016423.g002
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mesenteric artery of diabetic obese Zucker, and in Sprague-Dawley
rats during angiotensin II-induced hypertension [38,39], where
EDH is also impaired. Collectively, these data demonstrate the
presence ofsimilar alterations inthe potassiumchannel mechanisms
that underlie EDH in different models of vascular disease.
EDH dependence on SKCa and IKCa in the mesenteric artery of
normal adult rats was confirmed by selective SKCa and IKCa block
[3,7,40], and supported via direct endothelial SKCa and IKCa
activation with CyPPA and 1-EBIO, and subsequent apamin/
TRAM-34 block [16,28,29,30,41]. In mesenteric artery from
obese rats, functional IKCa upregulation in arteries from obese rats
is consistent with increased IK1 (IKCa) expression and redistribu-
tion in such vessels; TRAM-34 reducing EDH to a greater extent
in arteries of obese compared to control rats (by ,93 cf/. 60%,
respectively; Fig. 4C). Conversely, apamin reduced EDH to a
Figure 3. Combination SKCa and IKCa-mediated function. Representative membrane potential recordings show impaired hyperpolarization to
ACh (1 mM) in pressurized obese, compared to control rat mesenteric artery (A, inset; impaled propidium iodide identified muscle cell; longitudinal
vessel axis, left to right; bar, 10 mm). Hyperpolarization and relaxation to ACh were abolished by apamin (50 nM) and TRAM-34 (1 mM), confirming
endothelium-derived hyperpolarization patency (B; Table S3). Hyperpolarization and relaxation could also be induced by the SKCa and IKCa agonists
CyPPA (30 mM) and 1-EBIO (300 mM), with subsequent block by apamin and TRAM-34 (C; Table S3). Arteries from obese animals were further
associated with a constriction beyond resting tone (B, C). *P,0.05 from own control; y, P,0.05 control compared to obese. DEm, change in
membrane potential from own control.
doi:10.1371/journal.pone.0016423.g003
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arteries from control and obese rats, and abolished the associated relaxation in control (A; Tables S2 and S3). Hyperpolarization and relaxation elicited
by CyPPA (SKCa agonist; 30 mM) is abolished by apamin (B; Tables S2 and S3). EDH activity was abolished in arteries from obese rats following
inhibition of IKCa, and was reduced in arteries from control rats (C; Table S3). Hyperpolarization and relaxation elicited by 1-EBIO (300 mM; activating
IKCa) was larger in arteries from obese compared to control, with both being inhibited by TRAM-34 (D; Tables S2 and S3). *P,0.05 from own control;
y, P,0.05 control compared to obese. DEm, change in membrane potential from control.
doi:10.1371/journal.pone.0016423.g004
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,70 cf/. 60%, respectively; Fig. 4A), supporting a reduced
functional contribution of SKCa to EDH in obese. The lack of
difference in CyPPA-induced EDH in control compared to obese
may be due to its ability to sensitize SKCa to calcium [42], and a
potential differential ability of vascular cells in disease states to
buffer intracellular calcium, as previously described in obese and
hypertensive rat models [43,44].
In arteries from both control and obese rats, potential exists for
the direct transfer of EDH from the endothelium to the smooth
muscle via myoendothelial gap junctions (Figs. 1, 8), and such
activity occurs in normal rat mesenteric artery [11,12]. In contrast
to the present study where myoendothelial gap junction density
was the same in artery from control and obese rats, decreased
myoendothelial gap junctional coupling was suggested to impair
rat mesenteric artery EDH-type relaxation in Zucker obese
insulin-resistant rats [15]; although quantification of such coupling
was not undertaken in that study. However, in the Zucker, the
underlying Cx-mediated mechanisms at such sites may be altered
(for vascular Cx regulation review [45]), without a change in gap
junction density. Furthermore, whilst medial hypertrophy occurs
in the mesenteric artery of obese compared to control rats, similar
to that observed in the rat saphenous artery during development
[46], it had no apparent effect on EDH magnitude. Indeed,
altered gap junctional coupling between adjacent vascular smooth
muscle cells may be compromised in disease [45], resulting in a
reduction in the apparent relative contribution of EDH to
vasodilation in such states. Moreover, under disease conditions,
such as diabetes, hypertension and obesity, structural changes in
the vessel wall are typical [47], with diet-induced obese rat
mesenteric artery having an increased media-to-lumen ratio,
typical for resistance vessels in some vascular disease states [47,48].
Since no difference in the passive diameters of control and obese
rat mesenteric artery occurred, the present data are consistent with
inward remodeling of obese rat mesenteric artery [48]. Addition-
ally, consistent with these data, increased media-to-lumen ratio
and medial thickness occur in small human subcutaneous
resistance arteries in severe obesity where endothelium-dependent
relaxation is impaired [49].
In this study, the putative gap junction uncoupler carbenox-
elone was used in an attempt to assess the functional role of gap
junctional coupling to EDH. Although this agent inhibits ACh-
mediated EDH in mesenteric artery from control and obese rats, it
had little effect on EDH-mediated relaxation; consistent with
previous observations in rat mesenteric artery [13]. Since it has
previously been shown that carbenoxelone prevents EDH by
limiting the generation of EDH itself [50], it is unlikely that the
reduced smooth muscle hyperpolarization observed in the present
study is due to altered cellular coupling, but rather to non-gap
junction channel, receptor and/or store effects of this inhibitor
[50,51]. Indeed, the specificity of other putative gap junction
inhibitors such as the Cx-mimetic peptides and halothane has also
been questioned [52,53], ruling out their additional use in this
study.
Individual aspects of the EDH mechanism may act synergisti-
cally or in parallel, via K
+ efflux into the myoendothelial space,
activating smooth muscle Na
+K
+-ATPase and endothelial Kir to
evoke membrane hyperpolarization, or via direct current transfer
Figure 5. SK3 and IK1 distribution. Confocal immunohistochemisty demonstrates SK3 (SKCa) and IK1 (IKCa) distribution in arteries from control
(i–iv) and obese (v–viii) rat (NB. same vessel region shown in i–iii and v–vii, respectively). Autofluorescence demonstrates internal elastic lamina
(IEL) morphology and associated holes (i–iii, and v–vii, examples arrowed) as potential myoendothelial gap junction/microdomain sites. IKCa labeling
shows intense punctate localization at discrete points in the endothelium of arteries from control and obese rats (i–iii and v–vii, respectively), which
correlates to IEL hole sites (examples with arrows; see Table S1) to a greater extent in obese (v–vii) compared to control (i–iii; examples of IEL holes
without IKCa localization arrowed, asterisk; see Table S1). Aggregates of IKCa densites of .1 plaque occur in control and obese arteries (example,
boxed region in ii shown in iii, inset). Reconstructed confocal series of the full endothelial depth show diffuse SKCa labeling across the cell surface and
cytoplasm of control (iv) and obese (viii) rat arteries, and lack of localization to IEL hole sites. IKCa and SKCa were absent in smooth muscle (i, right
inset; iv, inset). Controls, as peptide block (i, left inset and viii, inset, respectively) and incubation in secondary antibody alone (data not shown) show
absence of labeling. In all panels, longitudinal vessel axis runs left to right (example, iv). Bar, 20 mm; inset box width, 5 mm.
doi:10.1371/journal.pone.0016423.g005
K+-Mediated Vasodilator Signaling in Obesity
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channel- and myoendothelial gap junction-mediated EDH
mechanisms thus not necessarily being interdependent in the rat
mesenteric artery. Indeed, myoendothelial contact sites are present
in mesenteric and other arteries that do not have gap junction
characteristics [54,55], consistent with the possibility that such
contact sites are where localized potassium release, but not
necessarily gap junction mediated coupling occurs; with Table S2
data supporting this proposition (IEL hole myoendothelial gap
junction and IKCa densities being different).
In arteries from control rats, ouabain and barium reduced ACh-
mediated EDH by ,50%, supporting the functional contribution
of Na
+K
+-ATPase, Kir and myoendothelial gap junctions in this
artery, as previously suggested [13]. However, in the present study,
barium and ouabain abolish ACh-mediated EDH in mesenteric
arteries from obese animals. Together with the KCa data, this
suggests that significant aspects of the EDH mechanism are altered
in obesity. Since inhibition of Kir with barium reduced EDH by a
few mV without effect on the associated relaxation in obese rat
artery, the small effect on smooth muscle membrane potential
implies that some Kir remain in such vessels; although the level is
apparently below standard confocal immunohistochemistry pro-
tocol detection limits. Whilst the functional role of Na
+K
+-ATPase
is considered in the present study, consideration of the anatomical
role of these channels was limited by lack of reliable antibody.
Interestingly, a reduction in endothelial Kir function has been
shown to underlie obesity-related endothelial dysfunction in
arteries of human forearm [22].
In the present study, diet-induced obesity results in IKCa
upregulation, which was mirrored by a ,3-fold increase in IK1
(IKCa) expression and concomitant reduction in SKCa function.
Functional data suggest that an interaction of IKCa and Na
+K
+-
ATPase is primarily responsible for EDH in mesenteric artery of obese
rat. Furthermore, a differential spatial association of KCa and Kir
reflect functional changes in their contribution to EDH (Fig. 8). The
present data suggest that restoration of endothelial potassium channel
activity represents a potential selective target to correct endothelial
vasodilator function in cardiovascular disease, such as that present in
obesity. Future work will examine the nature of the EDH signaling
mechanism in human arteries in health and disease, with a particular
focus on clarifying whether the altered potassium channel signalling
mechanism observed here is conserved between species, to confirm
whether this mechanism is a valid target for therapeutic correction.
Materials and Methods
Animals, dietary intervention and biochemical
parameters
All experiments were performed in accordance with the
guidelines of the National Health and Medical Research Council
of Australia and the Animal Experimentation Ethics Committees
of the University of New South Wales (approval ID 09/43B) and
the Australian National University.
Eight week old male Sprague Dawley rats were fed normal
chow (control; ,12% kJ as fat) or a cafeteria-style high fat diet
(obese; ,30% kJ as fat) for 16–20 weeks. The latter obese diet
consisted of ground chow with commercially available condensed
milk, meat pies, pasta, cakes and dims sims. The ,30% fat content
of this diet has previously been shown to result in characteristics
typical of human dietary obesity, such as elevated blood pressure,
glucose, insulin, leptin and triglycerides [24,25]. Food was
provided ad lib and body weight and food intake monitored
weekly over the intervention period, with animals aged 24–28
weeks at termination. High-fat and control diets were available ad
lib throughout, with non-fasted glucose, leptin and insulin, and
retroperitoneal and gonadal fat and organ mass being measured
immediately upon sacrifice. Glucose was measured in fresh blood
samples taken via cardiac puncture (Accu-Chek Advantage,
Australia, Castle Hill), with separated plasma being used to
measure plasma insulin and leptin (Linco Research, USA).
Figure 6. IK1 expression in control and obese rat mesenteric
artery. Western blot data shows IK1 (IKCa; A–D) expression in
membrane extracts from control and obese rat mesenteric artery. High
molecular weight SDS and heat resistant complexes are present (A)
which have been demonstrated as the functional homotetrameric IKCa
channels, whilst the monomeric ,48 kDa IKCa protein is also present
(A). Blots were stripped, reprobed with actin antibody and IKCa
quantification normalized to b-actin expression (B); showing a
significant increase in the relative intensity of IKCa (D) in obese rat
arteries. As a control, antibody incubation in corresponding IKCa
peptide shows absence of labeling (C). Lane M; molecular weight
markers. Arrows indicate the position of the full length protein.
*, significantly different from control (P,0.05; D).
doi:10.1371/journal.pone.0016423.g006
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+/K
+ATPase and Kir activity, and Kir distribution. Combined Na
+/K
+ATPase and Kir inhibition with ouabain (100 mM) and barium
(30 mM), respectively, attenuates ACh-mediated hyperpolarization and relaxation in control, and abolished the response in obese rat vessels (A). In
arteries of control, barium alone reduced EDH activity, whilst in obese, barium alone had no effect on vessel diameter, although the ACh-evoked
hyperpolarization was attenuated (B; Table S3). *P,0.05 from own control; y, P,0.05 control v obese. DEm, change in membrane potential from
control. Confocal immunohistochemistry demonstrates Kir distribution in control (Ci–iii) and obese (Civ–vi) rat arteries (same region shown in i–iii
and iv–vi, respectively). Autofluorescence demonstrates internal elastic lamina (IEL) morphology and associated holes (Ci, iv, examples arrowed) as
potential myoendothelial gap junction sites. In control arteries, Kir labelling shows intense punctate localization at discrete points in the endothelium,
including in close proximity to a proportion of IEL holes (Cii–iii, examples arrowed); an observation absent in obese rat vessels (iv–vi, arrows with
asterisks indicate examples of such sites, vi). Kir labelling was absent in the smooth muscle of both control and obese arteries (insets, Ciii, vi,
respectively), whilst endothelial labelling in control was blocked by pre-incubation in Kir antibody antigenic peptide (Cii, inset). Longitudinal vessel
axis runs left to right (example, v). Bar, 20 mm.
doi:10.1371/journal.pone.0016423.g007
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Rats were anaesthetized with thiopental sodium (100 mg/kg;
i.p.). Mesenteric arteries (4
th order collateral branches) were
isolated and placed into cold (5–7uC) dissection buffer containing
(mM): 3 Mops; 1.2 NaH2PO4; 4.6 glucose; 2 pyruvate; 0.02
EDTA (Na); 0.15 albumin; 145 NaCl; 4.7 KCl; 2 CaCl2; 1.2
MgSO4. Artery segments were then cannulated with two glass
micropipettes, secured using 10-0 nylon surgical sutures (Alcon,
Australia) and mounted in a 3–5 ml recording chamber (Living
Systems, USA). Arterial segments were superfused (3 ml min
21)
with physiological salt solution (PSS; mM): 111 NaCl; 25.7
NaHCO3; 4.9 KCl; 2.5 CaCl2; 1.2 MgSO4; 1.2 KH2PO4; 11.5
glucose; 10 HEPES; gassed with 5% CO2 in nitrogen (37uC,
pH 7.4); and pressurized under no flow conditions to 40 mmHg
by connecting the inflow pipette to a pressure servo and peristaltic
pump (Living Systems, USA; see [56]). Vessels were allowed to
equilibrate for 40 min, following which, pressure steps in
10 mmHg increments from 40 to 80 mmHg were applied every
10 min. Spontaneous tone was typically seen to develop at the
completion of this protocol. In order to obtain optimal
physiological myogenic and drug responsiveness, the stability of
the cannulation was tested at the onset of each experiment by
transiently increasing luminal pressure to 110 mmHg. Only vessels
without pressure leaks and displaying subsequent spontaneous
myogenic tone were studied. The vessel diameter was continuously
measured using video-microscopy (DIAMTRAK [57]). Drug
solutions were superfused, except for 1-EBIO (300 mM) and
CyPPA (30 mM) which were applied luminally, and allowed to
equilibrate for at least 30 mins before responses were recorded. All
recordings were made in the presence of indomethacin (10 mM),
L-NAME (100 mM) and ODQ (10 mM) to inhibit prostaglandins,
NO synthase and guanylyl cyclase, respectively. To obtain the
maximum vessel diameter (Dmax), at the end of experiments,
arteries were exposed to 0 mM Ca
2+ PSS containing 2 mM
EGTA.
Smooth muscle cells were impaled with sharp microelectrodes
(120–185 MV) filled with propidium iodide (0.2% in 0.5 M KCl)
to confirm cellular identity. Membrane potential recordings were
amplified with an Axoclamp 900A (Molecular Devices, USA) and
stored for analysis using pClamp software (v.10; Molecular
Devices, USA). Successful recordings were characterized by an
abrupt signal deflection upon cell impalement and an approximate
return to pre-impalement values on removal of the microelectrode.
Confocal immunohistochemistry
Rats were anaesthetized as described for isolated artery
preparations and perfused with a clearing solution containing
0.1% NaNO3, 0.1% BSA and 10 U/ml heparin, followed by 2%
paraformaldehyde in PBS for 10 min. Alternative fixation was also
carried out on freshly isolated and dilated (0.1% NaNO3) vessels in
cold acetone for 5 min. Mesenteric arteries, as above, were
isolated, cut along the longitudinal plane and pinned out as a flat
Figure 8. Model EDH mechanism. In arteries from control (A), agonist (ACh) elicits increased endothelial [Ca
2+]i and subsequent endothelial
membrane SKCa and IKCa activation (1), including at IKCa densities at potential myoendothelial gap junction (MEGJ)-related microdomain signaling
sites (2). The resulting endothelial hyperpolarization can spread to the smooth muscle via MEGJs (3). The hyperpolarization is amplified by smooth
muscle Na
+/K
+-ATPase activation and endothelial Kir, following SKCa and IKCa-mediated K
+ efflux into the extracellular space (4), some of which are
located at potential MEGJ-related signaling domains (Fig. 5Cii, iii; see also [13]). Smooth muscle hyperpolarization occurs (5), with closure of
voltage-dependent calcium channels (6) and subsequent vessel relaxation (7). In arteries from obese animals (B), SKCa and IKCa are primarily located
on the endothelial cell membrane (1); with IKCa incidence at MEGJ-related signaling domains being significantly decreased compared to control (2;
Table S1). Since MEGJ incidence is unaltered, and the number of smooth muscle cell (SMC) layers increased in obesity compared to control, MEGJ-
dependent EDH transfer may not be a sufficient driving force for smooth muscle relaxation. Under these circumstances, and in the absence of
detectable Kir, EDH is primarily attributable to activation of smooth muscle Na
+/K
+-ATPase, following K
+ efflux from primarily endothelial cell
membrane SKCa and IKCa (3). Once sufficient hyperpolarization occurs (4), voltage-dependent calcium channels close (5) and relaxation results (6).
doi:10.1371/journal.pone.0016423.g008
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rats were then incubated in the same well, in blocking buffer
containing 1% BSA, 0.2% Tween 20 for 2 h at room temperature,
rinsed (365 min) in PBS and further incubated in primary antibody
to SK3 (SKCa; 1:100, Chen, M75) and IK1 (IKCa; 1:100, Chen,




Cruz, sc-16043 and 39391, respectively) in blocking buffer for 18 h
at 4uC. The tissue was again rinsed (365 min) and incubated in
species-specific secondary antibody (Alexa Fluor 633; Invitrogen,
Australia, A21070 and A21082, as appropriate), diluted in 0.01%
Tween 20 for 2 h. Preparations were given a final 365 min rinse in
PBS, mounted in anti-fade media and examined with a confocal
microscope (Olympus FV1000) using uniform settings. Sequential
images were recombined to create a single image incorporating all
of the endothelial cell or smooth muscle cell labeling, above or
below the focal plane of the internal elastic lamina (IEL),
respectively. Individual sections within the IEL near the inner
smooth muscle cell membrane were recombined with the same
sections viewed at 488 nm excitation, to show IEL autofluorescence
and potential myoendothelial microdomain sites, as previously
described in this vessel [5,10]. CellR software (Olympus) was used
for quantitative measurements.
For KCa,K ir and Na
+/K
+ATPase antibodies, controls for
specificity involved antibody peptide block, incubation without
primary and absence of smooth muscle (KCa/Kir) or endothelial
(Na
+/K
+ATPase) staining in the same tissue sample; the latter
effectively being an internal negative control. Additional KCa
antibody controls previously conducted involved further positive
and negative controls with transfected cells, Western blotting and
immunoelectron microscopy [10,33,34,52,58]. Of note, this protocol
has previously been shown to successfully label antigens expressed in
smooth muscle cells [52], thus demonstrating that antibody access
w a sn o tal i m i t i n gf a c t o ri nt h ea b s e n c eo fl a b e l i n gi nt h i sc e l ll a y e r .
Western blotting
Mesenteric arteries, as above, were dissected from age-matched
control and obese rats, extraneous tissue was carefully removed and
the arteries were stored in liquid nitrogen. Vessels from 4 animals per
‘n’( n=3 and 4, for each obese and control lane, respectively) were
collected. The arteries were ground in liquid nitrogen using a pestle
and mortar, resuspended in phosphate buffered saline (PBS) pH 7.4
containing complete protease inhibitor cocktail (Roche) and
centrifuged (30006 g, 4uC, 5 min). The supernatant was removed
and placed on ice and the pellet was snap frozen in liquid nitrogen
and processed again as described above. Following the second spin
the supernatants were pooled and centrifuged (25,0006g; 4uC; 1 h)
and the supernatant, enriched in cytosolic proteins, was aliquoted,
snap frozen in liquid nitrogen and stored at 280uC. The membrane-
enriched pellet was carefully resuspended in PBS containing 0.1%
Triton X-100 and protease inhibitor cocktail, aliquoted, snap frozen
in liquid nitrogen and stored at 280uC. Protein concentration of the
samples was determined using the Bradford protein assay (BioRad).
Aliquots of protein extracts (5 mg protein unless otherwise
indicated) were dissolved in lithium dodecyl sulfate (LDS) sample
buffer (0.5% LDS, 62.5 mM Tris-HCl, 2.5% glycerol, 0.125 mM
EDTA, pH 8.5) for 10 min at 70uC. The samples were separated
by electrophoresis in 4–12% bis-Tris polyacrylamide gels using
MES SDS running buffer and electroblotted onto PVDF
membranes overnight at 4uC, according to the manufacturer’s
recommendations (Invitrogen). Following transfer, blots were
thoroughly washed, blocked, probed with primary antibody
(Table S4 and S5) and specific binding was visualized using
alkaline phosphatase-conjugated secondary antibody and chemi-
luminescence according to the manufacturer’s instructions (In-
vitrogen). The intensity of the band corresponding to each protein
was quantified by digital densitometry using ImageJ software
(NIH). Relative intensity for each protein was determined by
comparison with the intensity of actin staining on blots that were
stripped and then reprobed with actin primary antibody (Fig. 6).
To determine specificity, each antibody was incubated with its
cognate peptide in order to block specific binding. Prior to use, peptide
was added to antibody in a 1:1 ratio (w/w), mixed and incubated at
37uC for 1 h, then overnight at 4uC. The blocked antibody was then
used in Western blotting detection as described above.
Serial section transmission electron microscopy
Rats were anaesthetized as above and mesenteric arteries from
control and diet-induced obese animals dissected after perfusion
fixation (1% paraformaldehyde, 3% glutaraldehyde in 0.1 mM
sodium cacodylate buffer with 10 mM betaine, pH 7.4), with short
segments of artery being processed for electron microscopy [46].
Serial transverse sections (,100 nm thick) were cut over ,5 mmo f
vessel length. Myoendothelial gap junctions were identified according
to their characteristic pentalaminar membrane structure, and
together with their surrounding endothelial and smooth muscle
regions were counted and imaged at 610–40 k magnification at 16
megapixel resolution (camera from Scientific Instruments and
Applications, Inc., Duluth, USA). Quantitative wall measurements
were made from vessel cross-sections cut 90u perpendicular to the
longitudinal vessel axis from ultrastructural montages taken at61.5–
2.5 k at 16 megapixel resolution. Diameter was calculated from IEL
circumference, and media to lumen ratio from medial thickness
divided by lumen diameter. The number of smooth muscle cell layers
was counted as the mean of cell profiles .5 mm long, 90u apart.
CellR software was used for gross quantitative measurements.
Drugs
Apamin, ACh, L-NAME, indomethacin, barium, ODQ and
ouabain were obtained from Sigma-Aldrich (USA). TRAM-34, 1-
EBIO was purchased from Toronto Research Chemicals (Canada)
and Tocris (UK) and CyPPA obtained from NeuroSearch A/S
(Denmark). All stock solutions were prepared in distilled water
except for ODQ, 1-EBIO and TRAM-34 which were dissolved in
DMSO, which was without effect at 100 mM.
Analysis and statistics
Drug effects were determined by expressing the diameter as a
percent of the maximum vessel diameter (% Dmax) recorded in 0
Ca
2+ PSS with 2 mM EGTA. Results are given as a mean 6 SEM
of n rats. Statistical analysis was determined using 95% confidence
limits (P,0.05), Student’s t test for paired or unpaired data or one-
way ANOVA, as indicated for specific protocols. Data analysis
and graph production were performed using GraphPad Prism.
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